Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01541592 · ClinicalTrials.gov registry record · NA
Does Class of Dietary Fat Affect Insulin Resistance?
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01541592: Completed NA study, sponsored by Mayo Clinic.
NCT01541592 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01541592, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
It has been shown that intravenous fatty acids given to normal volunteers in the form of heparin and lipid emulsions will cause insulin resistance in a matter of a few hours. It is not known if this same phenomenon can be demonstrated with oral fat. The investigators are specifically interested in whether or not there are differences in the induction of insulin resistance between the 3 main classes of fatty acids (saturated, monounsaturated and polyunsaturated). The investigators also plan to evaluate endothelial dysfunction and blood pressure; both of which frequently accompany insulin resistance.
Interventions
- OTHER Dietary fat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01541592
The ClinicalTrials.gov registry entry for NCT01541592 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dietary fat is the first listed.
NCT01541592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01541592 about?
NCT01541592 is a clinical study titled "Does Class of Dietary Fat Affect Insulin Resistance?". It has been shown that intravenous fatty acids given to normal volunteers in the form of heparin and lipid emulsions will cause insulin resistance in a matter of a few hours. It is not known if this same phenomenon can be demonstrated with oral fat. The investigators are specifically interested in w...
What is the current status of trial NCT01541592?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-03. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01541592?
The interventions under investigation include: Dietary fat (OTHER).
Who is sponsoring clinical trial NCT01541592?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.